Merck & Co., Inc. (NEO:MRK)

Canada flag Canada · Delayed Price · Currency is CAD
19.03
+0.75 (4.10%)
Apr 25, 2025, 4:00 PM EDT
Market Cap 288.54B
Revenue (ttm) 91.88B
Net Income (ttm) 25.06B
Shares Out n/a
EPS (ttm) 9.89
PE Ratio 11.51
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,217
Average Volume 10,047
Open 18.28
Previous Close 18.28
Day's Range 18.07 - 19.08
52-Week Range 17.50 - 22.39
Beta n/a
RSI 49.22
Earnings Date Apr 24, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Cboe Canada
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.